Experts Debate AQUILA Trial Findings in Smoldering Multiple Myeloma Phase III trial sparks discussion on defining and managing high-risk smoldering myeloma Dec 16, 2024 video
Randy Moss Has Cancer; Nancy Pelosi's Surgery; Possible Bird Flu Case Hospitalized Health news and commentary gathered by MedPage Today staff Dec 16, 2024
A Setback for TNBC Monitoring With Circulating Tumor DNA in ZEST Trial Study was stopped early due to enrollment issues, but lessons can still be learned Dec 15, 2024
Homing in on Anthracyclines' High-Risk Niche in Early Breast Cancer Significant improvement in 5-year distant relapse-free interval with higher risk score Dec 14, 2024
Better Quality of Life With RT vs Endocrine Therapy in Older Breast Cancer Patients Radiotherapy also resulted in fewer treatment-related adverse events Dec 13, 2024
Hair Growth After Cancer; 'Global' Early-Onset CRC; Retifanlimab Boosts OS in NSCLC News, features, and commentary about cancer-related issues Dec 13, 2024
No Apparent Harm From Omitting Lymph Node Dissection in Selected Breast Cancers Nearly identical 5-year outcomes with no surgery, sentinel lymph node biopsy Dec 13, 2024
Palbociclib Regimen Yields 'Incredible' PFS Gain in Metastatic Breast Cancer Study results are "historic," expert says Dec 12, 2024
Risk-Reducing Surgery May Benefit BRCA Carriers With Early-Onset Breast Cancer Lower rates of mortality and cancer recurrence with mastectomy, salpingo-oophorectomy Dec 12, 2024
Skip Surgery for DCIS in Favor of Active Monitoring? No invasive cancer increase at 2 years, but editorialists say data don't back active monitoring Dec 12, 2024
Lung Cancer Drug Osimertinib Tied to Cardiac Events, Even in Low-Risk Patients Signal largely driven by newly emerging arrhythmias Dec 12, 2024
Industry Clinic • Ad Insights Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients Dec 12, 2024
Pulled Myeloma Drug Improves Survival in Trial DREAMM-7 findings help pave the way for Blenrep's return Dec 12, 2024
Oral SERD Impresses in Advanced Breast Cancer With ESR1 Mutations However, imlunestrant failed to improve PFS among entire trial population Dec 11, 2024
One CAR T-Cell Therapy for Multiple Myeloma Tops Another in Propensity Matched Study Higher response rate, PFS, OS with cilta-cel, but ide-cel had lower rate of severe toxicity Dec 11, 2024
Cancer Patients Who Completed Medication Survey Received More Help From Pharmacists Study assessed pharmacist interventions for adverse events Dec 11, 2024
Pirtobrutinib Delays Progression in CLL Already Treated With a BTK Inhibitor But no overall survival benefit seen in confirmatory trial Dec 11, 2024
Tafasitamab-Based Combination Boosts PFS in Relapsed/Refractory Follicular Lymphoma Benefit seen in all prespecified subgroups, including high-risk patients Dec 11, 2024
USPSTF Plans Changes to Cervical Cancer Screening Recommendations Self-collected HPV testing is a new addition Dec 10, 2024
Generous Blood Transfusions Not Beneficial for Some With Burst Brain Aneurysms SAHARA rounds out this year's notable trials on blood transfusions in critically ill patients Dec 10, 2024
Benefits of Transplant for Pediatric Sickle Cell Disease Add Up a Decade Later Better disease outcomes, measures of cognition, and quality-of-life vs standard care, study finds Dec 10, 2024
Transplantation Fails to Improve Survival in Mantle Cell Lymphoma New standard of care for patients in first remission? Dec 10, 2024
Lentiviral Gene Therapy Shows Promise in Severe Hemophilia A Increased factor VIII levels to mild or moderate range, with annualized bleeding rate of zero Dec 10, 2024
Year in Review: Chronic Lymphocytic Leukemia Top news in 2024 included the first CAR-T approval for CLL, triplet regimens, and more Dec 10, 2024
Industry Clinic • Ad Insights Alecensa (alectinib) Offers Hope for Certain Patients With ALK Positive NSCLC Dec 10, 2024
Hydroxyurea Shows Some Benefits in Milder Sickle Cell Disease Treatment tied to fewer vaso-occlusive pain events, hospitalizations versus placebo Dec 09, 2024
Fixed-Duration Oral Doublet for Fit CLL Wins in Frontline Setting AMPLIFY trial paves the way for FDA approval of acalabrutinib plus venetoclax Dec 09, 2024
Treatment of Smoldering Myeloma Cuts Progression Rate in Half Daratumumab significantly improved PFS, OS, but identity of high-risk population remains elusive Dec 09, 2024
Promising Results With Epcoritamab Monotherapy in Relapsed/Refractory CLL Complete responses seen in 43% of patients in expansion cohort of EPCORE CLL-1 study Dec 08, 2024
Novel BTK Inhibitor Succeeds in Heavily Pretreated Immune Thrombocytopenia Rilzabrutinib specifically designed to reduce platelet-targeting autoantibodies Dec 08, 2024
Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma Two-thirds of phase II patients had a complete response at 12 weeks of treatment Dec 08, 2024
Dietary Intervention Shows Promise in Blood Cancers High-fiber diets tied to improved outcomes in stem-cell transplants, slowing myeloma precursors Dec 08, 2024
Texting to Improve Adherence to CVD Medications; Detecting Maternal Cancers Also in TTHealthWatch: U.S. drug prices under Medicare's price negotiation system Dec 07, 2024 podcast
Dual Targeted CAR-T Yields 99% Response Rate in Pediatric ALL Cytokine release syndrome developed in all patients, including grade 3/4 events in nearly half Dec 07, 2024
New Standard for Newly Diagnosed Pediatric B-Cell Acute Lymphoblastic Leukemia Blinatumomab consolidation reduced risk of relapse by 61% versus chemotherapy alone Dec 07, 2024
Eltrombopag Improves Outcomes in Kids With Newly Diagnosed ITP Drug may potentially "transform" approach to upfront treatment, investigator says Dec 07, 2024
Experts Wrestle Over Uses of PFAS During Senate Hearing Industry witness warns of unintended consequences of blanket bans Dec 06, 2024
Self-Pay, AI-Enhanced Breast Cancer Screening Detected More Cancers Overall cancer detection rate was about 43% higher versus women who chose not to participate Dec 06, 2024
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns News, features, and commentary about cancer-related issues Dec 05, 2024
Nearly 6 Million Deaths From Five Major Cancer Types Averted Since 1975 Prevention and screening efforts accounted for 80% of those averted deaths Dec 05, 2024